Revenue and profit growth driven by strong pharmaceutical- and food-related performance in the Lifestyle Industries business

A theme of higher revenue and profit in the Lifestyle Industries business, driven by pharmaceutical-related demand for materials used in new drugs, active pharmaceutical ingredients for generics and pharmaceutical intermediates, improved profitability in food-related operations, and an expanded consolidation scope.